WHO/HIV/2014.27 © World Health Organization 2014
Appendix 6: Summary of declared interests of members of Guidelines Development Group for the development of WHO HCV guidelines for screening, care, and treatment of persons with HCV infection Level of Participation Participants Declared interests Vladimir Chulanov Wahid Doss Nicolas Durier Personal: Travel grants from Bristol Myers Squibb (BMS) Institutional: Research grants from BMS Personal: Travel grant from Abbott Institutional: Research grant from Gilead Personal: None Intstitutional: Drug donation from Merck Personal: Travel grants Merck and Roche and speakers' honorarium from Merck Institutional: Personal: None Institutional: President of World Hepatitis Alliance that receives grants from Achillion, Bayer, BMS, Boehringer Ingelheim, Gilead, GSK, Janssen, Merck, Roche Personal: Consulting fees from Achilon, Astex, Bayer, BMS, Glaxo Smith Kline (GSK), Gilead, Janssen, Novartis, Merck, Roche Institutional: Research grants from Abbott, BMS, Gilead, GSK, Merck, Roche Personal: Holder of patent for hepatitis diagnostic test Partial participation
Full participation Full participation Partial participation
Manal Hamdy ElSayed Charles Gore
Partial participation
Partial participation
Anna Lok
Partial participation
Masashi Mizokami John Parry
Shiv Kumar Sarin
Tracy Swan
Personal: None Full participation Institutional: Research grants from Gilead and Ireland Fellowship Program Full participation Personal: None Institutional: Research grants from Indian government research institutions Full participation Personal: None Institutional: Employing institution receives numerous individual contributions and institutional grants. Among these are grants from BMS, Boehringer Ingelheim, Genentech, Gilead, Janssen, Vertex